跳至主要内容
临床试验/ISRCTN41082378
ISRCTN41082378已完成不适用

ew therapeutic approach to Tourette Syndrome in children based on a randomised placebo-controlled double-blind phase IV study of the effectiveness and safety of magnesium and vitamin B6

The Carlos III Health Institute (Instituto de Salud Carlos III) (Spain)0 个研究点目标入组 38 人开始时间: 2008年9月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 7 - 14 years, either sex. This is the age bracket during which the natural course of the illness is most exacerbated. Before the age of 7 years, the tics may not yet have appeared (this generally occurs at the age of 5 - 7 years). After 14 years, symptoms tend to stabilise.
  • 2. Informed consent of the child's parents or guardians, and reasoned agreement with the child
  • 3. Clinical diagnosis of TS, according to Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV) criteria
  • 4. Score of 40 or more on the YGTSS

排除标准

  • 1. Severe attention deficit hyperactivity disorder (ADHD) or obsessive compulsive disorder (OCD), not clinically controlled
  • 3. Unrelated depression
  • 4. Allergy to acetylsalicylic acid (due to the excipients used)

研究者

发起方
The Carlos III Health Institute (Instituto de Salud Carlos III) (Spain)

相似试验